Human Infection from Avian-like Influenza A (H1N1) Viruses in Pigs, China by Yang, Huanliang et al.
Human Infection 
from Avian-like 
Inﬂ  uenza A (H1N1) 
Viruses in Pigs, 
China
Huanliang Yang,1 Chuanling Qiao,1 Xu Tang, 
Yan Chen, Xiaoguang Xin, and Hualan Chen
In investigating inﬂ  uenza in an immunodeﬁ  cient child in 
China, in December 2010, we found that the inﬂ  uenza virus 
showed high sequence identity to that of swine. Serologic 
evidence indicated that viral persistence in pigs was the 
source of infection. Continued surveillance of pigs and 
systemic analysis of swine inﬂ  uenza isolates are needed.
H
umans have been infected with avian-like swine 
inﬂ   uenza A (H1N1) viruses (SIVs) several times 
since the ﬁ  rst case was diagnosed in Switzerland in 1986 
(1). These cases generally occur in persons who have direct 
exposure to pigs (2–4). On December 31, 2010, a 3-year-old 
boy in rural Jiangsu Province, People’s Republic of China, 
who had chronic renal disease (for which he was given 
long-term steroid treatment), sought care with inﬂ  uenza-
like symptoms. Laboratory tests at the Chinese Center for 
Disease Control and Prevention yielded a positive result 
for European avian-like A (H1N1) SIV, indicating that the 
European avian-like SIV also caused human infection in 
the Asia-Paciﬁ  c region.
The Study
After notiﬁ   cation of the boy’s infection from the 
Ministry of Health, we performed active public health 
surveillance to locate the origin of the infection. A total 
of 60 nasal swab specimens were collected from pigs at 
the patient’s family farm and a local slaughterhouse. 
Each swab was placed in 2 mL of minimal essential 
medium supplemented with penicillin (2,000 U/mL) 
and streptomycin (2,000 U/mL). Virus was isolated by 
using 10-day-old speciﬁ   c pathogen-free embryonated 
chicken eggs. Hemagglutinin (HA) and neuraminidase 
(NA) subtypes were determined as described (5). Three 
A (H1N1) SIVs were obtained, including 2 isolates from 
pigs in the slaughterhouse and 1 from a pig raised at the 
family’s farm. Viral RNA was extracted and reverse 
transcribed under standard conditions by using the Uni12 
(5′-AGCAAAAGCAGG-3′) primer. The viral genomes 
were ampliﬁ  ed by PCR and sequenced by using segment-
speciﬁ  c primers (sequences available on request). Genomic 
sequencing ultimately showed that the 3 isolates were 
virtually identical, and the sequence of the entire genome 
of the representative strain A/swine/Jiangsu/40/2011 
(Sw/JS/40/11) is available in GenBank (accession nos. 
JQ319645–JQ319652). Unrooted phylogenetic trees were 
generated by using MEGA5 software (www.megasoftware.
net). The A (H1N1) viruses isolated in this study fell 
into the European avian-like swine A (H1N1) lineage 
(Figure 1). The homology of the polymerase basic protein 
(PB) 2, PB1, polymerase acidic protein, HA, nucleocapsid 
protein, NA, matrix (M), and nonstructural protein genes 
between the Sw/JS/40/11 virus and the A/Jiangsu/1/2011 
(JS/1/11) virus, which was isolated from the child, were 
99.3%, 99.3%, 99.3%, 99.7%, 99.7%, 99.4%, 99.6%, and 
99.1%, respectively, indicating that they might have been 
derived from the same ancestor.
The receptor-binding property of the HA protein is 
a major molecular determinant of host range. The amino 
acids at sites 190 and 225 of HA are major determinants of 
the receptor-binding speciﬁ  city of the A (H1N1) virus, and 
the mutations E190D and D225E in HA switch the virus 
receptor-binding speciﬁ  city from α-2,3–linked sialosides to 
α-2,6–linked sialosides (6). The Sw/JS/40/11 and JS/1/11 
isolates have the amino acids D at site 190 and E at site 
225 within the HA protein, which implies that these viruses 
might preferentially bind to α-2,6–linked sialosides. 
Potential glycosylation sites (PGSs) also have a major 
effect on the antigenic and receptor-binding properties of 
inﬂ  uenza A viruses. Molecular analysis showed that the 2 
Jiangsu strains had 5 PGSs in their HA1 proteins, 4 of which 
were the same as those of the A/Netherlands/386/1986 virus 
(the cause of the ﬁ  rst avian-like SIV infection in a human). 
Antigenic sites in the H1 HAs, i.e., Sa, Sb, Ca1, Ca2, and 
Cb, were compared between A/Netherlands/386/1986 
and JS/1/11. Amino acid mutations H159N, K238R, and 
G239E were observed at the Ca2 site; R187G at the Ca1 
site; and T202D, N203S, S207T, and A212N at the Sb 
site. Compared with JS/1/11, the unique mutation D204V, 
located at the Sb site, which is an antigenic site near the 
receptor-binding site in inﬂ   uenza virus (7), occurred 
in the HA1 of Sw/JS/40/11 (Figure 2). No oseltamivir 
resistance–conferring substitutions (H274Y and N294S) 
were observed in the NA proteins of the 2 viruses, which 
suggests that they are sensitive to NA inhibitors (8). The 
amino acid sequence of the M2 protein of the 2 isolates did 
not contain the I27T or S31N substitution, characteristic 
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of amantadine resistance in inﬂ  uenza viruses (9,10). The 
627K and 701N residues in the PB2 protein contribute to 
the replication and transmission of avian inﬂ  uenza viruses 
in mammalian hosts (11–14). Similar to most avian-like A 
(H1N1) SIVs, both isolates (JS/1/11 and Sw/JS/40/11) had 
701N in their PB2 gene.
Chicken antiserum against different subtype H1N1 
or H1N2 SIVs were used for antigenic analysis. The Sw/
JS/40/11 virus reacted with the antiserum against the 
classical A (H1N1) SIV (A/swine/Guangdong/6/2010), the 
triple reassortant A (H1N2) SIV (A/swine/Tianjin/1/2007), 
inﬂ  uenza A(H1N1)pdm09 (A/swine/Heilongjiang/44/2009), 
and the avian-like SIV (A/swine/Henan/11/2005) (Table), 
but not with the antiserum against the human-like A (H1N1) 
SIV (A/swine/Hebei/15/2009). Antiserum against Sw/
JS/40/11 reacted only with the avian-like A (H1N1) SIV 
and the human-like A (H1N1) SIV, but the HI titers against 
the human-like A (H1N1) SIV were 4-fold lower than 
those against the avian-like A (H1N1) SIVs. These results 
suggest that the H1 subtype SIVs circulating in China differ 
antigenically.
We investigated antibody responses in 20 serum 
samples from pigs at the patient’s family farm and the 
local slaughterhouse. Serologic assays showed that the 
seroprevalence of antibodies to the avian-like A (H1N1) 
SIVs was 55% and to classical A (H1N1) SIVs and 
A(H1N1)pdm09 virus were 25% and 30%, respectively. 
Furthermore, antibodies against A(H3N2) SIVs were 
observed but at the low rate of 10%.
Conclusions
We showed that similar viruses were simultaneously 
prevalent in a local pig population when a child was infected 
with an avian-like A (H1N1) SIV. Speciﬁ  cally, isolation of 
avian-like SIV from a family farm provides direct evidence 
for the origin of the human infection. No further spread of 
the Sw/JS/40/2011-like swine strain occurred, according 
to the limited information available; however, the incident 
aroused interest in inﬂ  uenza in animals, especially in pigs. 
Antigenic analysis showed that this avian-like A (H1N1) 
SIV was antigenically divergent from classical A (H1N1) 
and human-like A (H1N1) SIVs currently circulating in 
China, which was further reinforced by the heterogeneity 
of their genetic relationships. Since early avian-like A 
(H1N1) SIV isolates in humans, amino acid mutations in 
the antigenic sites and PGS changes might have altered 
the antigenic properties in the avian-like A (H1N1) 
SIV cluster. Our data highlight the need to characterize 
circulating strains antigenically and genetically through 
regular inﬂ  uenza virus surveillance.
Pigs can serve as intermediate hosts for inﬂ  uenza 
viruses to evolve toward efﬁ  cient replicability in humans. 
The classical A (H1N1) SIVs and European avian-like 
A (H1N1) SIVs have circulated worldwide in pigs since 
1930 and 1979, respectively, and a classical A (H1N1) 
SIV emerged in humans as a triple reassortant, causing the 
2009 inﬂ  uenza pandemics (15). Although the virulence and 
transmissibility of the avian-like A (H1N1) SIVs remain 
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Figure 1. Phylogenetic tree of selected swine, human, and avian 
H1 hemagglutinin 1 sequences. An unrooted phylogenetic tree 
was generated by the distance-based maximum-likelihood method 
by using MEGA5 software (www.megasoftware.net). Bootstrap 
values were calculated on the basis of 1,000 replications; A/swine/
Jiangsu/40/2011 is in boldface. Scale bar indicates nucleotide 
substitutions per site.
Figure 2. Multiple alignment of 
hemagglutinin protein sequences. 
Epitopes Sa, Sb, Ca1, Ca2, and Cb 
are indicated. Triangle, Sa; circle, 
Sb; square, Ca1; hexagon, Ca2; 
diamond, Cb. Putative glycosylation 
sites are indicated in blue-lined 
boxes.to be evaluated, recurrent human infections with avian-like 
A (H1N1) SIVs suggest that after long-term adaptation in 
pigs, the avian-like A (H1N1) SIVs already can replicate 
in humans. After further whole-genome adaptation to 
the human host or reassortment with other viruses, novel 
strains bearing the avian-like swine subtype H1N1 HA gene 
are highly likely to be generated with pandemic potential. 
Continued surveillance of swine and systemic analysis of 
swine inﬂ  uenza isolates are clearly needed.
Acknowledgments
We thank Susan Watson for editing the manuscript.
This study was supported by the 973 Program 
(2011CB505001, 2010CB534001), the Chinese National Science 
Fund for Distinguished Young Scholars (30825032), Harbin 
Municipal S&T Plan (2009AA6BN078), and the Scientiﬁ  c 
Research Program of the State Key Laboratory of Veterinary 
Biotechnology (NKLVSP201013).
Dr Yang is a veterinary microbiologist in the Harbin 
Veterinary Research Institute, Chinese Academy of Agricultural 
Sciences, China. His research interests are the surveillance and 
molecular epidemiology of SIVs.
References
    1.    de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. 
A pandemic warning? Nature. 1997;389:554. http://dx.doi.
org/10.1038/39218
  2.   de Jong JC, Paccaud MF, de Ronde-Verloop FM, Huffels NH, Ver-
wei C, Weijers TF, et al. Isolation of swine-like inﬂ  uenza A(H1N1) 
viruses from man in Switzerland and the Netherlands. Ann Inst 
Pasteur Virol. 1988;139:429–37. http://dx.doi.org/10.1016/S0769-
2617(88)80078-9
  3.   Myers KP, Olsen CW, Gray GC. Cases of swine inﬂ  uenza in hu-
mans: a review of the literature. Clin Infect Dis. 2007;44:1084–8. 
http://dx.doi.org/10.1086/512813
  4.   Adiego Sancho B, Omenaca Teres M, Martinez Cuenca S, Rodrigo 
Val P, Sanchez Villanueva P, Casas I, et al. Human case of swine 
inﬂ  uenza A (H1N1), Aragon, Spain, November 2008. Euro Surveill. 
2009;14:pii=19120.
  5.   World Organisation for Animal Health. Manual of diagnostic tests 
and vaccines for terrestrial animals 2010. Chapter 2.8.8. Version 
adopted by the World Assembly of Delegates of the OIE in May 
2010 [cited 2012 Feb 23]. http://www.oie.int/ﬁ  leadmin/Home/eng/
Health_standards/tahm/2.08.08_SWINE_INFLUENZA.pdf
  6.   Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Ca-
strucci MR, et al. Early alterations of the receptor-binding properties 
of H1, H2, and H3 avian inﬂ  uenza virus hemagglutinins after their 
introduction into mammals. J Virol. 2000;74:8502–12. http://dx.doi.
org/10.1128/JVI.74.18.8502-8512.2000
    7.    Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for 
high virulence of Hong Kong H5N1 inﬂ  uenza A viruses. Science. 
2001;293:1840–2. http://dx.doi.org/10.1126/science.1062882
  8.   Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, et al. 
The H274Y mutation in the inﬂ  uenza A/H1N1 neuraminidase active 
site following oseltamivir phosphate treatment leaves virus severely 
compromised both in vitro and in vivo. Antiviral Res. 2002;55:307–
17. http://dx.doi.org/10.1016/S0166-3542(02)00053-0
  9.   Saito R, Sakai T, Sato I, Sano Y, Oshitani H, Sato M, et al. Frequency of 
amantadine-resistant inﬂ  uenza A viruses during two seasons featuring 
cocirculation of H1N1 and H3N2. J Clin Microbiol. 2003;41:2164–5. 
http://dx.doi.org/10.1128/JCM.41.5.2164-2165.2003
10.    Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, 
Kawaoka Y. High frequency of resistant viruses harboring differ-
ent mutations in amantadine-treated children with inﬂ  uenza. J Infect 
Dis. 2003;188:57–61. http://dx.doi.org/10.1086/375799
11.   Subbarao EK, London W, Murphy BR. A single amino acid in the 
PB2 gene of inﬂ  uenza A virus is a determinant of host range. J Virol. 
1993;67:1761–4.
12.   Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, et al. Molecular ba-
sis of replication of duck H5N1 inﬂ  uenza viruses in a mammalian 
mouse model. J Virol. 2005;79:12058–64. http://dx.doi.org/10.1128/
JVI.79.18.12058-12064.2005
13.   Steel J, Lowen AC, Mubareka S, Palese P. Transmission of inﬂ  u-
enza virus in a mammalian host is increased by PB2 amino acids 
627K or 627E/701N. PLoS Pathog. 2009;5:e1000252. http://dx.doi.
org/10.1371/journal.ppat.1000252
14.   Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, et al. Identiﬁ  ca-
tion of amino acids in HA and PB2 critical for the transmission of 
H5N1 avian inﬂ  uenza viruses in a mammalian host. PLoS Pathog. 
2009;5:e1000709. http://dx.doi.org/10.1371/journal.ppat.1000709
15.   Gibbs AJ, Armstrong JS, Downie JC. From where did the 
2009 ‘swine-origin’ inﬂ   uenza A virus (H1N1) emerge? Virol J. 
2009;6:207. http://dx.doi.org/10.1186/1743-422X-6-207
Address for correspondence: Hualan Chen, Harbin Veterinary Research 
Institute, Chinese Academy of Agricultural Sciences, 427 Maduan St, 
Harbin 150001, People’s Republic of China; email: hlchen1@yahoo.com
DISPATCHES
1146  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 7, July 2012
Table. Antigenic analysis of H1 swine influenza viruses, People’s Republic of China* 
Virus
HI antibody titers of chicken antiserum against† 
Classical swine 
A (H1N1) 
Triple-reassortant 
A (H1N2) 
A (H1N1) 
pdm09 
Human seasonal 
A (H1N1) 
Avian-like swine 
A (H1N1)‡ 
Avian-like swine 
A (H1N1)§ 
Classical swine A (H1N1)  512 512 512  ¶  8  ¶ 
Triple-reassortant A (H1N2)  1024  512 1,024 ¶  8  ¶ 
A(H1N1)pdm09 512  512  1,024  ¶ 16 ¶ 
Human seasonal A (H1N1)  16  32  64  32 32 64 
Avian-like swine A (H1N1)‡  128  64  128  ¶  512 256
Avian-like swine A (H1N1)§  32  16  64  ¶  256  256
*Classical swine A (H1N1), A/swine/Guangdong/6/2010; triple-reassortant A (H1N2), A/swine/Tianjin/1/2007; A(H1N1)pdm09, 
A/swine/Heilongjiang/44/2009; human seasonal A (H1N1), A/swine/Hebei/15/2009.
†Antiserum was generated by inoculating specific pathogen-free chickens with an oil-emulsified inactivated vaccine derived from the indicated viruses. 
Homologous titers are shown in boldface.
‡A/swine/Jiangsu/40/2011.  
¶HI titer <2. 
§A/swine/Henan/11/2005. 